Dr n. med.

Joanna Kubicka

Choroby wewnętrzne, choroby zakaźne

Since 1994 she has been dealing with patients with various infectious diseases and since 2002 she has been dealing with HIV-infected patients. In his practice he applies post-exposure prophylaxis (PEP) for HIV and other blood-borne infections. She also deals with the pre-exposure prophylaxis of HIV infection (PREP). It provides patients with a wide range of infectious diseases, sexually transmitted diseases and internal medicine.

Within the group of experts, PTN AIDS is involved in the prevention and treatment of cardiovascular diseases in HIV infected patients. Her dissertation concerned the borderline between infectious diseases and haematology - replication of HCV and HGV in the bone marrow of patients with haematological disorders.

She believes that good diagnostics and treatment require a comprehensive view of the patient's body.


Award of the Minister of Health for a series of publications on HCV infection

PTN AIDS Awards for publications

Awards of international liver disease associations.


2007 - obecnie

Prophylactic and Medical Clinic in Warsaw

2002 - 2006

Voivodship Infectious Hospital in Warsaw

1994 - 2001

Observation and Infection Ward of the Voivodship Hospital Complex in Kielce


Akademia Medyczna w Krakowie

Uniwersytet Wrocławski (studia doktoranckie)


English, Russian


Kubicka J, Ignatowska A, Kowalska JD, Cielniak I, Pulik P, Bakowska E, Chylak A, Burkacka Firlag E, Horban A Saquinavir/r containing initial antiretroviral therapy (ART)-long term evaluation in Polish Observational Cohort of HIV/AIDS Patients (POLCA) Study Group HIV & AIDS Review Volume 12, 2014

Siwak E, Kubicka J, Kowalska JD, Bakowska E, Swiecki P, Pulik P, PIetraszkiewicz E, Burkacka Firlag E, Horban A Safety and effectiveness of lopinavir/ritonavir twice-daily in cART naïve patients with HIV-1 infection: Data from POLCA Study Group, HIV & AIDS Review Volume 13, Issue 4 , Pages 120-124 , 2014

Ankiersztejn-Bartczak M1, Firląg-Burkacka E, Czeszko-Paprocka H, Kubicka J, Cybula A, Horban A, Kowalska J. Factors responsible for incomplete linkage to care after HIV diagnosis: preliminary results from the Test and Keep in Care (TAK) project. HIV Med. 2014 Aug 15

Kubicka J, Siwak E, Horban A: Opieka nad pacjentem zakażonym HIV leczonym antyretrowirusowo w programie kompleksowej ambulatoryjnej opieki specjalistycznej. In: Zalecenia PTN AIDS dotyczące zasad opieki nad osobami zakażonymi HIV. (Care of the HIV patient with antiretroviral treatment in complex specialists out-patient care system). Cop. Polskie Towarzystwo Naukowe AIDS

Firląg-Burkacka E, Kalinowska M, Siwak E, Gizińska J, Kubicka J, Swiecki P, Horban A: Comparison of effectivness of different methods of prevention of mother-to-child HIV Transmission, HIV & AIDS Review Volume 8, Issue 4, 2009

Firlag-Burkacka E, Cielniak I, Swiecki P, Siwak E, Gizinska J, Bakowska E, Kubicka J, Kowalski J, Podlasin R, Horban A. The increasing prevalence of neurosyphilis and high serum VDRL titers in HIV positive patients — Data from outpatient clinic in Warsaw, Poland (POLCA Cohort) HIV & AIDS Review Volume 12, Issue 2, 2013

Radkowski M, Gallegos-Orozco JF, Jablonska J, Colby TV, Walewska-Zielecka B, Kubicka J, Wilkinson J, Adair D, Rakela J, Laskus T: Persistence of hepatitis C virus in patients successfully treated for chronic hepatitis C. Hepatology 2005 Jan; 41(1)

Syczewska- Wawrzynowicz M, Kubicka J, Boroń-Kaczmarska A, Radkowski M Natural history of acute symptomatic hepatitis type C. Infection. 2004 Jun;32(3):138-43.

Kamińska A, Kmera-Muszyńska M, Kubicka J, Radkowski M: Powikłania oczne leczenia interferonem alfa. Okulistyka Polska 2003.09 (Eye complications of IFN alpha treatment.)

Aniszewska M., Cianciara J., Kubicka J., Radkowski M Transmisja wertykalna HCV – czynniki predysponujące i częstość zakażenia. Pediatria Polska 2004; 5: 351–361.

Radkowski M, Kubicka J, Kisiel E, Cianciara J, Nowicki M, Rakela J, Laskus T: Detection of active hepatitis C virus and hepatitis G virus/GB virus C replication in bone marrow in human subjects. Blood. 2000 Jun 15;95(12)

Brojer E, Kryczka W, Medynska J, Grabarczyk P, Kubicka J, Gloskowska-Moraczewska Z, Loch T, Cianciara J, Juszczyk J, Bolewska B, Zupanska B. Anti-HCV RIBA/LiaTek reactivity and HCV genotype in EIA-negative patients with viremia. J Med Virol. 1999 Dec;59(4)

E. Dutkiewicz, W. Kryczka, A. Urbaniak, P. Pabjan, Kubicka J Nonalcoholic steatohepatitis (NASH) as diagnostic problem Journal of Hepatology , 1998 , 28 , Supplement

Radkowski M, Laskus T, Horban A, Kubicka J, Ślusarczyk J, Specific antibody response and activation of the immune system in the early stages of infection with human immunodeficiency virus type 1, Central-European Journal of Immunology, 1997, 22

Designed and developed by   Jalappeno software house   | Smart Life Clinic © 2021